IAS CONFERENCE ON HIV SCIENCE 2021
IAS 2021: Virtual Conference from 18-21 July
The biennial International AIDS Society (IAS) conference, was virtually hosted from a local partner hub in Berlin from the 18th to the 21st of July 2021. The 11th edition presented the critical advances in clinical and operational research, helping to drive forward HIV science into policy and practice around the world.
ViiV Healthcare joined some of the world’s leading experts and professionals in HIV research to present important new data that will drive forward our field and help improve the quality of life of people living with HIV.
Our team shared exciting updates and perspectives around the treatment and prevention of HIV, as well as ideas on how we can address the ever-changing needs of people living with HIV by providing more options on when and how people take their medicines. Dr Benjamin Young, Head of the Global Medical Directors at ViiV Healthcare, shared his views on the hot topics covered at this year’s congress.
Find out more about IAS 2021 via social media using #IAS2021 or #WeWontStop.
For regular updates and news from ViiV Healthcare, follow us on Twitter, Facebook, LinkedIn or Instagram.
A message from Harmony Garges, Senior Vice President and Chief Medical Officer, ViiV Healthcare
MORE FROM ViiV HEALTHCARE AT IAS 2021
Click here to find out about the hot topics throughout the week
Read the recap of our IAS 2021 community event
Investors and media – click here to find out about our press releases at the conference
THERE’S MORE TO US THAN JUST HIV TREATMENT
Together, we can cure HIV
Real people, real stories: HIV in view
Living with HIV? Today, it’s just living
For people living with HIV. Resources and information about living well with HIV.
For news and media. Latest news and press releases via our media centre.
For healthcare professionals, Information about ViiV medicines and data.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.